ABBVIE'S COMMITMENT TO

E X C E P T I O N A L

PATIENT SUPPORT

RINVOQ Complete provides your patients support to help them
start and stay on track with their prescribed treatment plan.

One exceptional patient experience

RINVOQ® Complete logo.
Nurse ambassadors icon.
One-To-One
Support

Nurse Ambassadors* and
Access Specialists provide
1-to-1 support to help
navigate insurance.

Access specialists icon.
Affordability

Eligible commercially-insured patients pay as little as $5 per month on their prescription and can be reimbursed for the out-of-pocket costs of related lab tests and monitoring.

Access and savings icon.
Access

No charge for eligible patients experiencing initial insurance denial for up to 24 months.

Access and savings icon.
Streamlined
Enrollment Process

Get started with a single enrollment form.

*Nurse Ambassadors are provided by AbbVie and do not provide medical advice or work under the direction of the prescribing health care professional (HCP). They are trained to direct patients to speak with their HCP about any treatment-related questions, including further referrals.

How to help enroll patients in RINVOQ Complete

Help patients get the support they need to start and stay on track with their prescribed treatment plan.

1

Download the appropriate enrollment & prescription form for your specialty

2

Fill out the form with your patient

  • This form enrolls your patient and can be used to initiate a prescription with your patient’s preferred specialty pharmacy
  • Section 6 may help your commercially insured patients get access to RINVOQ if they experience a delay or denial in their insurance coverage
3

Fax the form to 1-678-727-0690

  • You will receive a call from an Access Specialist to discuss next steps
  • If using the Pharmacy Prescription in Section 9, fax a copy to your patient’s specialty pharmacy as well
4

Inform your patient that they have been enrolled

  • Let your patient know to expect a call from their Nurse Ambassador

RINVOQ Complete Enrollment Forms

Have questions or need support over the phone?
Call 1.877.COMPLETE (1.877.266.7538)

Get RINVOQ access & reimbursement forms, as well as helpful guides for you and your patients

RINVOQ Complete app tile.

Complete App

Track treatment

The RINVOQ Complete App helps patients with their treatment plan by allowing them to:

  • Access additional resources, including a savings card for those that are eligible
  • Set customized medication reminders
  • Log and share symptoms with HCPs
  • Log medication lot number and medication expiration date
Download the RINVOQ Complete App on the IOS App store.
Get the RINVOQ Complete App on Google Play.
Computer with keyboard and mouse icon.

CompletePRO.com

Streamline the Rx process

CompletePro.com enables seamless enrollment into RINVOQ Complete and helps smooth the prescription process for your patients.

With CompletePro.com, you can:

  • Request benefits verifications
  • Complete and submit prior authorizations
  • Send prescriptions to the patient’s specialty pharmacy of choice, with the option to include a savings card
  • Receive alerts for annual reauthorizations and renewals
  • Track and monitor where patients are in the prescription process

Terms and Conditions apply. This benefit covers RINVOQ® (upadacitinib) alone or, for rheumatology patients, RINVOQ plus one of the following medications: methotrexate, leflunomide, or hydroxychloroquine. Benefit also covers certain lab tests to monitor for specific parameters as recommended in the product label where the full cost is not covered by patients’ insurance through the Complete Rebate program (Maximum savings limit of $1,000.00 per year applies). Eligibility: Available to patients with commercial insurance coverage for RINVOQ who meet eligibility criteria. Co-pay assistance program is not available to patients receiving reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the RINVOQ Complete Savings Card and patient must call RINVOQ Complete at 1-800-2RINVOQ to stop participation. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from the RINVOQ Complete Program from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. Subject to all other terms and conditions, the maximum annual benefit that may be available solely for the patient’s benefit under the co-pay assistance program is $14,000.00 per calendar year. The actual application and use of the benefit available under the co-pay assistance program may vary on a monthly, quarterly, and/or annual basis, depending on each individual patient’s plan of insurance and other prescription drug costs. With the exception of patients enrolled in a health plan subject to Maine insurance law, patients who are members of insurance plans that claim to reduce or eliminate their patients' out-of-pocket co-pay, coinsurance, or deductible obligations for certain prescription drugs based upon the availability of, or patient's enrollment in, manufacturer sponsored co-pay assistance for such drugs (often termed "maximizer" programs) will have an annual maximum program benefit of $6,000.00 per calendar year. This assistance offer is not health insurance. By redeeming this card, you acknowledge that you are an eligible patient and that you understand and agree to comply with the terms and conditions of this offer. To learn about AbbVie’s privacy practices and your privacy choices, visit

.

Eligibility criteria: Available to patients aged 63 or younger with commercial insurance coverage. Patients must have a valid prescription for RINVOQ® (upadacitinib) for an FDA approved indication and a denial of insurance coverage based on a prior authorization request on file along with a confirmation of appeal. Continued eligibility for the program requires the submission of an appeal of the coverage denial every 180 days. Program provides for RINVOQ at no charge to patients for up to two years or until they receive insurance coverage approval, whichever occurs earlier, and is not contingent on purchase requirements of any kind. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Offer subject to change or discontinuance without notice. This is not health insurance and program does not guarantee insurance coverage. No claims for payment may be submitted to any third party for product dispensed by program. Limitations may apply.